🇩🇪 Germany · EU Public Tender
Arzneimittel mit dem Wirkstoff Rivaroxaban (ATC: B01AF01 - in der Wirkstärke 2,5 mg je abgeteilte orale Darreichungsform)
🏛️ AOK Sachsen - Anhalt · 📍 Magdeburg
—
Estimated value
30 April 2026
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Deadline | 30 April 2026 |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.